Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study

Conditions: Cystic Fibrosis Interventions: Other: Discontinuation of dornase alfa (Dnase); Other: Continuation of dornase alfa (Dnase) Sponsors: Nicole Hamblett; Cystic Fibrosis Foundation; Dartmouth-Hitchcock Medical Center; University of Washington Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials